Teva’s Austedo, struggling from a pandemic slowdown, needs huge gains to meet 2021 projections

Teva’s Austedo, struggling from a pandemic slowdown, needs huge gains to meet 2021 projections
esagonowsky
Wed, 10/27/2021 – 09:51